» Authors » Yu-Lueng Shih

Yu-Lueng Shih

Explore the profile of Yu-Lueng Shih including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 87
Citations 783
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Chang Y, Lee J, Chen C, Kao W, Lin C, Yang S, et al.
Aliment Pharmacol Ther . 2025 Feb; PMID: 39981689
Background: Data regarding the risk of incident type 2 diabetes (T2D) and prediabetes among patients with hepatitis C virus (HCV) achieving direct-acting antivirals (DAAs)-induced sustained virologic response (SVR) remains limited....
2.
Liao C, Chen P, Shih Y, Chang W, Hsieh T, Huang T
Prev Med Rep . 2025 Jan; 49():102951. PMID: 39807183
Objective: The noncompliance rate with routine or surveillance colonoscopies is high, and the underlying reasons remain unverified among Asian patients with inflammatory bowel disease (IBD). This study aimed to examine...
3.
Lu M, Huang T, Chen P, Chen H, Yang C, Lin J, et al.
Medicine (Baltimore) . 2024 Dec; 103(50):e40921. PMID: 39686487
Upper gastrointestinal angiodysplasia (UGIA) is a unique mucosal vascular lesion that causes acute or recurrent gastrointestinal bleeding. Despite the increasing incidence of UGIA, the risk factors for bleeding in this...
4.
Liu F, Wang C, Chen P, Shih Y, Lin H, Lin J, et al.
World J Clin Cases . 2024 Dec; 12(34):6696-6704. PMID: 39650821
Background: Small bowel tumors (SBTs) are a heterogeneous group of difficult-to-diagnose tumors that account for 2%-5% of all gastrointestinal tumors. Single-balloon enteroscopy greatly enhances the diagnosis and treatment of SBTs....
5.
Yeh C, Chen R, Wu T, Chang S, Hsieh T, Shih Y, et al.
Clin Epigenetics . 2024 Nov; 16(1):174. PMID: 39614377
Background: The progression of liver cancer is a complicated process that involves genetic and epigenetic changes. Paired box 6 (PAX6) is a critical transcription factor for embryonic development. PAX6 is...
6.
Huang H, Shiu T, Chan D, Chang C, Lin H, Lin J, et al.
Pancreatology . 2024 Nov; 24(8):1294-1301. PMID: 39500645
Background: Single nucleotide polymorphism (SNP) rs1347093 shows statistically significant association with lung cancer risk, but there is no further rs1347093 expression quantitative trait loci (eQTL) effect information. SNP rs1347093 is...
7.
Ho H, Shih Y, Huang T, Fang W, Liu C, Lin J, et al.
J Transl Med . 2024 Oct; 22(1):936. PMID: 39402603
Background: Metabolic dysfunction-associated steatohepatitis (MASH) is a growing global health concern with no effective pharmacological treatments. SNP-630, a newly developed synthetic molecule with multiple mechanisms of action, and a mixture...
8.
Liu C, Cheng P, Fang Y, Chen C, Kao W, Lin C, et al.
J Hepatol . 2024 Oct; PMID: 39368711
Background & Aims: Data are limited on the risk of de novo hepatocellular carcinoma (HCC) in patients with metabolic dysfunction-associated steatotic liver disease (MASLD) after achieving sustained virologic response at...
9.
Liu C, Chang Y, Lee J, Chen C, Kao W, Lin C, et al.
J Med Virol . 2024 May; 96(5):e29675. PMID: 38746997
Early confirmation of sustained virologic response (SVR) or viral relapse after direct-acting antivirals (DAAs) for hepatitis C virus (HCV) infection is essential based on public health perspectives, particularly for patients...
10.
Liu C, Chang Y, Fang Y, Cheng P, Chen C, Kao W, et al.
J Gastroenterol . 2024 Apr; 59(7):609-620. PMID: 38613690
Background: Information on the dynamics of metabolic dysfunction-associated steatotic liver disease (MASLD) among hepatitis C virus patients achieving sustained virologic response (SVR) with direct-acting antivirals (DAAs) is limited. Methods: We...